MedTrace Logo

Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States

NCT02959827 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2320

Last updated 2019-01-30

Study results available
· View outcomes & findings →

Summary

This study will estimate the incidence of hypothyroidism in a pediatric population of children under age 4, based on data from the US-based Kaiser Permanente Northern California database, which were exposed to iodinated contrast agent through having a diagnostic procedure.

Conditions

Interventions

DRUG

Iodinated contrast agents

Use of iodine contrast agents and doses following the decision of the treating physician.

Sponsors & Collaborators

Eligibility

Max Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-15
Primary Completion
2017-06-15
Completion
2017-06-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02959827 on ClinicalTrials.gov